Immutep Limited (IMM.AX) Stock Price, News & Chart

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0210

Open0.0220

Day range0.02100.0220

52-week range0.02100.4700

Off day high−4.55%

Off 52-week high−95.53%

Volume4.19M

Avg. volume (3M)9.22M

Market cap30.95M

EPS (TTM)-0.0500

Forward P/E-1.91

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)2.32

Shares outstanding1.47B

Short interest—

Earnings dateJul 29, 2025 (est.)

Analyst target0.1133

Profit margin0.00%

Against its peers

Compare in full ›

	IMM.AX	HURA	IMU.AX	ESLA	CHRS	0RC7.IL
Market cap	30.95M	109.61M	19.39M	19.29M	131.36M	58.79M
P/E (TTM)	—	—	—	—	—	—
Forward P/E	-1.9	-2.8	-0.9	-1.4	-1.3	—
Price/book	0.5	6.0	1.6	-2.6	2.2	11.9
Dividend yield	—	—	—	—	—	—
1-year change	−92.08%	−29.80%	−91.04%	−83.91%	−42.95%	+27.16%
Today	0.00%	+3.93%	+16.67%	+6.10%	+5.54%	+4.82%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Immutep's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
TuHURA Biosciences, Inc.HURA · Biotechnology	109.61M	1.7200	+3.93%
Imugene LimitedIMU.AX · Biotechnology	19.39M	0.0350	+16.67%
Estrella Immunopharma, Inc.ESLA · Biotechnology	19.29M	0.4435	+6.10%
Coherus Oncology, Inc.CHRS · Biotechnology	131.36M	0.8502	+5.54%
Hansa Biopharma AB (publ)0RC7.IL · Biotechnology	58.79M	41.36	+4.82%
Helix BioPharma Corp.HBP.TO · Biotechnology	70.27M	0.9200	0.00%
Scancell Holdings plcSCLP.L · Biotechnology	116.66M	85.99	+1.16%
Innate Pharma S.A.IPHA · Biotechnology	159.17M	1.4250	+5.56%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Edesa Biotech, Inc.EDSA · Markham, ON	29.32M	2.1700	−4.82%
BLIS Technologies LimitedBLT.NZ · Dunedin, New Zealand	31.98M	0.0250	0.00%
ProMIS Neurosciences, Inc.PMN · Toronto, ON	31.57M	3.5200	+3.23%
Aligos Therapeutics, Inc.ALGS · South San Francisco, CA	31.35M	5.02	+5.68%
Lite Strategy, Inc.LITS · San Diego, CA	32.84M	1.0800	+3.85%
IRulya Therapeutics Inc.IRLA · New Haven, CT	32.21M	31.67	−4.49%
Quince Therapeutics IncQNCX · South San Francisco, CA	32.27M	31.73	+8.07%
Alterity Therapeutics LimitedPBN.F · Melbourne, VIC	38.03M	0.1660	+3.75%

Healthcare companies of a similar market value (30.95M).

Company	Mkt cap	Price	Today
Stenocare A/SSTENO.CO · Drug Manufacturers - Specialty & Generic	31.45M	0.7280	+0.55%
Edesa Biotech, Inc.EDSA · Biotechnology	29.32M	2.1700	−4.82%
BLIS Technologies LimitedBLT.NZ · Biotechnology	31.98M	0.0250	0.00%
Cosmos Health Inc.COSM · Medical Distribution	32.97M	0.3276	+7.73%
InspireMD, Inc.NSPR · Medical Devices	36.31M	0.7810	+20.47%
ProMIS Neurosciences, Inc.PMN · Biotechnology	31.57M	3.5200	+3.23%
NeuPath Health Inc.NPTH.V · Medical Care Facilities	30.77M	0.5400	0.00%
Aligos Therapeutics, Inc.ALGS · Biotechnology	31.35M	5.02	+5.68%

Also based in Sydney, Australia, then elsewhere in Australia.

Company	Mkt cap	Price	Today
Commonwealth Bank of AustraliaCWW.F · Sydney, NSW	173.03B	103.50	−0.50%
Westpac Banking CorporationWBC.F · Sydney, NSW	77.36B	22.65	−2.14%
Atlassian CorporationTEAM · Sydney, NSW Odds	48.07B	189.88	−0.61%
Yancoal Australia LtdYA1.F · Sydney, NSW	4.91B	3.4690	−3.53%
QBE Insurance Group LimitedQBE.AX · Sydney, NSW	38.68B	25.89	−0.23%
Brambles LimitedBXB.AX · Sydney, NSW	29.18B	21.98	+3.29%
Evolution Mining LimitedWE7.F · Sydney, NSW	16.46B	8.05	+8.23%
Insurance Australia Group LimitedIAG.AX · Sydney, NSW	20.70B	8.85	−0.67%

Companies that serve the same markets: healthcare, life sciences.

Company	Mkt cap	Price	Today
Satellos Bioscience Inc.MSCL.TO · life sciences · healthcare	197.53M	9.31	+3.44%
Starpharma Holdings LimitedSPL.AX · life sciences · healthcare	222.14M	0.4600	+1.10%
Clinuvel Pharmaceuticals LimitedUR9.F · life sciences · healthcare	235.77M	4.6700	+8.58%
Mesoblast LimitedMSB.AX · life sciences · healthcare	2.82B	2.1700	+3.33%
Hemogenyx Pharmaceuticals PlcHEMO.L · life sciences · healthcare	38.97M	565.00	−6.61%
Helix BioPharma Corp.HBP.TO · life sciences · healthcare	70.27M	0.9200	0.00%
Sensorion SAALSEN.PA · life sciences · healthcare	94.53M	9.17	−0.30%
Veraxa Biotech AGJ8L0.F · life sciences · healthcare	118.08M	0.8350	0.00%

What visitors to Immutep's page also look at.

Company	Mkt cap	Price	Today
IMUGENE FPO [IMU]IMU.AX	19.39M	0.0350	+16.67%
TELIXPHARM FPO [TLX]TLX.AX	4.78B	14.08	+5.71%
MESOBLAST FPO [MSB]MSB.AX	2.82B	2.1700	+3.33%
NEUREN FPO NZ [NEU]NEU.AX	2.95B	23.24	+17.49%
PRESCIENT FPO [PTX]PTX.AX	60.62M	0.0530	+3.92%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All IMM.AX news ›

BioSpace·5d agoNegative

Layoff Tracker: Immutep, Molecular cut workforces

Taylor Tieden for BioSpace Below is a look at which companies are tightening their belts and cutting staff in 2026. For last year’s tracker entries, please visit the 2025 recap article. To see which biopharmas laid off employees in the…

AMZN MSFT NVS SNY

@kalkineau·3d agoNegative

Autoimmune Pivot: Can Immutep (ASX:IMM) Rewrite Its Story?

Has Gold Bottomed? What It Means for ASX 200's Ramelius (ASX:RMS) Unhedged and Exposed: Why Is ASX 200's Capricorn (ASX:CMM) on Watch? The month brings several scheduled events that could shape how the market views Immutep. The…

SLE IMUX NVS BMY

BioSpace·Oct 23Positive

Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026

The investigators concluded that the regimen demonstrated “no significant detriment to overall QoL during treatment”. The ePoster is available on the Posters & Publications page of Immutep’s website. About Eftilagimod Alfa (Efti) Efti’s…

NVS AZN EIKN

Stock Titan·Oct 19Positive

Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP) OpenWorld (NASDAQ: OPNW) Signs Definitive Merger…

IMMP

marker movers & expertise.·Oct 13Negative

Daily Special: Clever Culture Systems, Aureka, Immutep, Clean TeQ Water, Dundas Minerals

Sharecafe Daily Special: Clever Culture Systems, Aureka, Immutep, Clean TeQ Water, Dundas Minerals The Australian sharemarket extended its losses on Wednesday, with the S&P/ASX 200 falling 72.4 points, or 0.82

Stock Titan·Oct 14

Immutep and Monash University Secure Further ARC Linkage Projects Funding for LAG-3 Research

The project will use structural biology, cellular immunology and advanced imaging to investigate immune regulation. The research builds on the collaboration’s human LAG-3/MHC Class II crystal structure published in December 2024. Immutep…

IMMP META

Stock Titan·Oct 13·2 outletsNegative

Immutep regains Nasdaq bid-price compliance

The ADS ratio adjustment changed the number of ordinary shares represented by each ADS, while leaving Immutep’s ordinary shares unaffected. PURSUANT TO RULE 13a-16 OR 15d-16 Date as October 13, 2026 (Exact Name as Specified in its Charter)…

In the news

8mentions in 30 days

8with it in the headline

Negativesentiment

Most coverage from

stocktitan.net3
biospace.com2
globenewswire.com1
kalkinemedia.com1
sharecafe.com.au1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.